| Drug/DM | Brand name | INN | Pharmaceutical form | Strengths | Primary packaging | Therapeutic area |
CTD Dossier availability |
GMP |
Climatic zone |
|---|---|---|---|---|---|---|---|---|---|
| Drug | Linelid® | Linezolid |
Solution for infusion |
2 mg/ml, 300 ml |
Polymer bags |
Pulmonology, surgery, infectious diseases, tuberculosis |
Available |
UA - available |
IVb |
| Drug | Linelid® | Linezolid | Solution for infusion | 2 mg/ml, 300 ml | Polymer bottles | Pulmonology, surgery, infectious diseases, tuberculosis | Q4 2026 |
UA - available EU - Q4 2027 |
IVb |
| Drug |
Moxifloxacin |
Solution for infusion |
400 mg/ |
Polymer bottles |
Pulmonology, surgery, infectious diseases |
Available |
UA - available EU - Q4 2027 |
IVb |
|
| Drug | Leflocin® |
Levofloxacin |
Solution for infusion |
5 mg/ml, 100 ml |
Glass bottles |
Pulmonology, surgery, intensive care |
Available |
UA - available |
IVb |
| Drug | Leflocin® | Levofloxacin | Solution for infusion | 5 mg/ml, 100 ml | Polymer bottles | Pulmonology, surgery, intensive care | Available |
UA - available EU - Q4 2027 |
IVb |
| Drug | Ciprofloxacin |
Ciprofloxacin |
Solution for infusion |
2 mg/ml, |
Glass bottles, polymer bottles |
Surgery, intensive care |
Available |
UA - available |
IVb |
| Drug | Fluconazole | Fluconazole | Solution for infusion |
5 mg/ml, 50, 100 ml |
Glass bottles |
Surgery, infectious diseases, gynecology |
Available |
UA - available |
IVb |
| Drug | Fluconazole | Fluconazole | Solution for infusion | 5 mg/ml, 100 ml | Polymer bottles | Surgery, infectious diseases, gynecology | Q3 2025 |
UA - available EU - Q4 2027 |
IVb |